Torgerson P R, Carmona C, Bonifacino R
Department of Veterinary Microbiology and Parasitology, Faculty of Veterinary Medicine, University College Dublin, Ballsbridge, Dublin 4, Ireland.
Ann Trop Med Parasitol. 2000 Oct;94(7):703-13. doi: 10.1080/00034983.2000.11813594.
Cost-benefit analyses, run before the commencement of a programme to control a parasitic disease, should include estimates of the economic losses attributable to the disease. Uruguay, a middle-income, developing country, has a recent history of persistent problems with cystic echinococcosis, in both its human population and livestock. The economic effects in Uruguay of this disease, caused by the larval stage of the canine tapeworm Echinococcus granulosus, have now been evaluated. Data on the incidence of the disease, in humans and livestock, were used to construct cost estimates. The estimated minimum cost (U.S.$2.9 million/year) was based on the condemnation costs of infected offal together with the actual costs of the hospital treatment of the human cases. The estimate of the maximum cost (U.S.$22.1 million/year) also included the production losses resulting from lower livestock efficiency and the reduced income of individuals with morbidity attributable to the disease.
在启动控制寄生虫病的项目之前进行的成本效益分析，应包括对该疾病造成的经济损失的估计。乌拉圭是一个中等收入的发展中国家，近期在人类和牲畜群体中都持续存在囊型包虫病问题。现已评估了由犬绦虫细粒棘球绦虫的幼虫阶段引起的这种疾病在乌拉圭造成的经济影响。利用人类和牲畜中该疾病发病率的数据来构建成本估计。估计的最低成本（每年290万美元）基于感染内脏的报废成本以及人类病例的实际医院治疗成本。最高成本估计（每年2210万美元）还包括牲畜生产效率降低导致的生产损失以及该疾病导致发病个体的收入减少。
